Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$962M |
| 2 |
AbbVie
ABBV
|
+$512M |
| 3 |
Bank of America
BAC
|
+$172M |
| 4 |
TJX Companies
TJX
|
+$157M |
| 5 |
GE Vernova
GEV
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$636M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$388M |
| 3 |
Palantir
PLTR
|
+$253M |
| 4 |
Applovin
APP
|
+$236M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.84% |
| 2 | Technology | 16.54% |
| 3 | Financials | 9.27% |
| 4 | Industrials | 6.9% |
| 5 | Healthcare | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2976
Ligand Pharmaceuticals
LGND
$6.04B
| $2.28M | ﹤0.01% |
20,097
-40
| -0.2% | -$4.28K |
2024 Q4
2 quarters
|
|
|
IA
2977
Innovative Solutions & Support
IA
$333M
| $2.28M | ﹤0.01% |
164,479
+83,894
| +104% | +$762K |
2025 Q1
1 quarter
|
|
|
GLDD
2978
DELISTED
Great Lakes Dredge & Dock
GLDD
| $2.28M | ﹤0.01% |
187,094
+24,634
| +15% | +$256K |
2024 Q4
2 quarters
|
|
|
QXO.PRB
2979
QXO Inc 5.50% Series B Preferred Stock
QXO.PRB
$458M
| $2.28M | ﹤0.01% |
+36,745
| New | +$2.15M |
2025 Q2
0 quarters
|
|
2980
iShares International Small Cap Equity Factor ETF
ISCF
$658M
| $2.27M | ﹤0.01% |
58,561
+1,198
| +2% | +$43.2K |
2024 Q4
2 quarters
|
|
2981
Timothy Plan High Dividend Stock ETF
TPHD
$347M
| $2.26M | ﹤0.01% |
59,904
+481
| +0.8% | +$17.6K |
2024 Q4
2 quarters
|
|
2982
State Street SPDR S&P Global Infrastructure ETF
GII
$899M
| $2.26M | ﹤0.01% |
33,533
-1,640
| -5% | -$106K |
2024 Q4
2 quarters
|
|
2983
Global X S&P 500 Catholic Values ETF
CATH
$1.36B
| $2.26M | ﹤0.01% |
29,917
-1,964
| -6% | -$137K |
2024 Q4
2 quarters
|
|
2984
Intapp
INTA
$2.88B
| $2.26M | ﹤0.01% |
43,693
-23,289
| -35% | -$1.27M |
2024 Q4
2 quarters
|
|
2985
Ichor Holdings
ICHR
$2.34B
| $2.26M | ﹤0.01% |
114,830
-142,337
| -55% | -$2.61M |
2024 Q4
2 quarters
|
|
2986
Helmerich & Payne
HP
$3.82B
| $2.25M | ﹤0.01% |
148,557
+10,794
| +8% | +$198K |
2024 Q4
2 quarters
|
|
2987
iShares Russell Top 200 ETF
IWL
$2.24B
| $2.25M | ﹤0.01% |
14,670
+2,485
| +20% | +$350K |
2024 Q4
2 quarters
|
|
2988
Invesco KBW High Dividend Yield Financial ETF
KBWD
$362M
| $2.25M | ﹤0.01% |
161,894
+112,725
| +229% | +$1.52M |
2024 Q4
2 quarters
|
|
|
GNT
2989
GAMCO Natural Resources, Gold & Income Trust
GNT
$142M
| $2.24M | ﹤0.01% |
356,904
-36,312
| -9% | -$222K |
2024 Q4
2 quarters
|
|
2990
Unitil
UTL
$923M
| $2.24M | ﹤0.01% |
43,034
+3,104
| +8% | +$172K |
2024 Q4
2 quarters
|
|
2991
Crane NXT
CXT
$2.77B
| $2.23M | ﹤0.01% |
41,456
-3,680
| -8% | -$187K |
2024 Q4
2 quarters
|
|
2992
Capri Holdings
CPRI
$1.65B
| $2.23M | ﹤0.01% |
125,963
+10,132
| +9% | +$167K |
2024 Q4
2 quarters
|
|
|
PWRD
2993
TCW Transform Systems ETF
PWRD
$1.49B
| $2.23M | ﹤0.01% |
24,715
+10,070
| +69% | +$777K |
2024 Q4
2 quarters
|
|
2994
LeMaitre Vascular
LMAT
$1.83B
| $2.22M | ﹤0.01% |
26,791
-47,045
| -64% | -$3.93M |
2024 Q4
2 quarters
|
|
2995
Century Aluminum
CENX
$3.56B
| $2.22M | ﹤0.01% |
123,415
+20,809
| +20% | +$353K |
2025 Q1
1 quarter
|
|
|
MRX
2996
Marex Group Limited Ordinary Shares
MRX
$5.1B
| $2.22M | ﹤0.01% |
56,294
+33,223
| +144% | +$1.38M |
2025 Q1
1 quarter
|
|
2997
Takeda Pharmaceutical
TAK
$57.1B
| $2.22M | ﹤0.01% |
143,693
+61,511
| +75% | +$909K |
2024 Q4
2 quarters
|
|
2998
Ubiquiti
UI
$36.9B
| $2.22M | ﹤0.01% |
5,392
+425
| +9% | +$155K |
2024 Q4
2 quarters
|
|
2999
Inspire 100 ETF
BIBL
$494M
| $2.21M | ﹤0.01% |
53,508
+713
| +1% | +$27.6K |
2024 Q4
2 quarters
|
|
3000
Invesco Global Listed Private Equity ETF
PSP
$213M
| $2.21M | ﹤0.01% |
32,113
+2,876
| +10% | +$186K |
2024 Q4
2 quarters
|
|
Similar funds
Raymond James Financial's Q2 2025 Portfolio in Review
As of Q2 2025, Raymond James Financial held 7,081 positions worth $290B, up 9.4% from $266B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Raymond James Financial's Q2 2025 filing shows 2,183 new, 2,404 increased, 2,172 reduced and 80 closed positions. Its largest new stake was ServiceTitan Inc: 369,922 shares worth $39.6M. The largest sale was Merck, an estimated $636M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, down from 40% a quarter earlier, followed by Technology and Financials.
- Raymond James Financial's largest Q2 2025 buy was ServiceTitan Inc: 369,922 shares worth $39.6M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $962M increase.
- Raymond James Financial's biggest Q2 2025 reduction was Merck, cutting an estimated $636M.
- Raymond James Financial fully exited Discover Financial Services in Q2 2025, selling an estimated $36.8M.
- Raymond James Financial's ten largest holdings make up 22% of its $290B portfolio in Q2 2025.
- Raymond James Financial opened 2,183 new positions and closed 80 in Q2 2025.
- Raymond James Financial's portfolio value rose 9.4% quarter-over-quarter to $290B.
Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.